Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223501

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223501

MEA Colorectal Cancer Diagnostics Market - Industry Trends and Forecast to 2030

PUBLISHED:
PAGES: 220 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

Middle East and Africa colorectal cancer diagnostics market is projected to register a substantial CAGR of 6.9% from 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Middle East and Africa Colorectal Cancer Diagnostics Market, By Product Type (Instruments and Consumables & Accessories), Test Type (Stool Examination, Blood Test, Imaging Test, Tumor Markers, Biopsy, and Others), Stages (Stage 0, Stage I, Stage II, Stage III, and Stage IV), Cancer Type (Adenocarcinoma, Colorectal Lymphoma, Gastrointestinal Stromal Tumors, Carcinoid Tumors, and Others), Age Group (Geriatric, Adults, and Pediatric), End User (Hospital, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, Academic Institutes, and Others), Country (South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa) Industry Trends and Forecast to 2030.

Some of the factors that can affect the growth of the market are:

Rise in healthcare expenditure for cancer diagnosis and treatment

Novel technological advancements in cancer diagnostics

Market Players:

The key market players in Middle East and Africa colorectal cancer diagnostics market are listed below:

Koninklijke Philips N.V.

Quest Diagnostics Incorporated

Bio-Rad Laboratories, Inc.

Merck KGaA

FUJIFILM Corporation

Agilent Technologies, Inc.

BD

General Electric Company

Siemens Healthcare GmbH

Abbott

Neusoft Corporation

BioFire Diagnostics

QIAGEN

Hologic, Inc.

PlexBio

GE HealthCare.

TABLE OF CONTENTS

1 INTRODUCTION 43

  • 1.1 OBJECTIVES OF THE STUDY 43
  • 1.2 MARKET DEFINITION 43
  • 1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET 43
  • 1.4 LIMITATIONS 45
  • 1.5 MARKETS COVERED 45

2 MARKET SEGMENTATION 48

  • 2.1 MARKETS COVERED 48
  • 2.2 GEOGRAPHICAL SCOPE 49
  • 2.3 YEARS CONSIDERED FOR THE STUDY 50
  • 2.4 CURRENCY AND PRICING 50
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 51
  • 2.6 MULTIVARIATE MODELLING 54
  • 2.7 PRODUCT TYPE LIFELINE CURVE 54
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 55
  • 2.9 DBMR MARKET POSITION GRID 56
  • 2.10 MARKET END USER COVERAGE GRID 57
  • 2.11 VENDOR SHARE ANALYSIS 58
  • 2.12 SECONDARY SOURCES 59
  • 2.13 ASSUMPTIONS 59

3 EXECUTIVE SUMMARY 60

4 PREMIUM INSIGHTS 63

  • 4.1 PORTER'S FIVE FORCES 64
  • 4.2 PESTEL ANALYSIS 65

5 INDUSTRY INSIGHTS: 66

6 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, REGULATIONS 67

  • 6.1 REGULATORY SCENARIO IN THE U.S 67
  • 6.2 REGULATORY SCENARIO IN AUSTRALIA 67
  • 6.3 REGULATORY SCENARIO IN JAPAN 68
  • 6.4 REGULATORY SCENARIO IN CHINA 68

7 MARKET OVERVIEW 70

  • 7.1 DRIVERS 72
    • 7.1.1 GROWING PREVALENCE OF COLORECTAL CANCER 72
    • 7.1.2 RISE IN THE NUMBER OF PATIENTS SUFFERING FROM DIVERTICULITIS AND ULCERATIVE COLITIS. 72
    • 7.1.3 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS 72
  • 7.2 RESTRAINTS 73
    • 7.2.1 STRINGENT REGULATORY POLICIES 73
    • 7.2.2 HIGH COST FOR THE COLORECTAL CANCER TREATMENTS. 73
  • 7.3 OPPORTUNITIES 74
    • 7.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 74
    • 7.3.2 GOVERNMENT INITIATIVES TOWARD CANCER DIAGNOSTICS 75
    • 7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 75
  • 7.4 CHALLENGES 76
    • 7.4.1 INCREASED COST, SAFETY, AND CONVENIENCE ISSUES 76
    • 7.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 77

8 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 78

  • 8.1 OVERVIEW 79
  • 8.2 INSTRUMENTS 82
    • 8.2.1 PATHOLOGY-BASED INSTRUMENTS 83
      • 8.2.1.1 PCR INSTRUMENTS 83
      • 8.2.1.2 SLIDE STAINING SYSTEMS 83
      • 8.2.1.3 TISSUE PROCESSING SYSTEMS 84
      • 8.2.1.4 CELL PROCESSORS 84
      • 8.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS 84
    • 8.2.2 IMAGING INSTRUMENTS 84
      • 8.2.2.1 ULTRASOUND SYSTEMS 84
      • 8.2.2.2 CT SYSTEMS 84
      • 8.2.2.3 MRI SYSTEMS 85
      • 8.2.2.4 OTHERS 85
    • 8.2.3 BIOPSY INSTRUMENTS 85
    • 8.2.4 OTHERS 85
  • 8.3 CONSUMABLES & ACCESSORIES 85
    • 8.3.1 KITS 86
      • 8.3.1.1 PCR KITS 86
      • 8.3.1.2 DNA POLYMERASE KITS 86
      • 8.3.1.3 NUCLEIC ACID ISOLATION KITS 86
      • 8.3.1.4 OTHERS 87
    • 8.3.2 REAGENTS 87
      • 8.3.2.1 ASSAYS 87
      • 8.3.2.2 BUFFERS 87
      • 8.3.2.3 PRIMERS 87
      • 8.3.2.4 OTHERS 87
    • 8.3.3 OTHER CONSUMABLES 87

9 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE 88

  • 9.1 OVERVIEW 89
  • 9.2 STOOL EXAMINATION 92
  • 9.3 BLOOD TEST 92
    • 9.3.1 COMPLETE BLOOD COUNT (CBC) 93
    • 9.3.2 TUMOR MARKER TEST 94
    • 9.3.3 LIVER ENZYME BLOOD TEST 94
  • 9.4 IMAGING TEST 94
    • 9.4.1 COMPUTED TOMOGRAPHY (CT) SCAN 95
    • 9.4.2 MRI 95
    • 9.4.3 ULTRASOUND 95
    • 9.4.4 POSITION EMISSION TOMOGRAPHY (PET) 96
    • 9.4.5 OTHERS 96
  • 9.5 TUMOR MARKERS 96
    • 9.5.1 CARCINOEMBRYONIC ANTIGEN (CEA) 97
    • 9.5.2 CA19-9 BIOMARKER TEST 97
    • 9.5.3 CA 50 MARKER TEST 97
    • 9.5.4 OTHERS 97
  • 9.6 BIOPSY 97
  • 9.7 OTHERS 98

10 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES 99

  • 10.1 OVERVIEW 100
  • 10.2 STAGE III 103
  • 10.3 STAGE IV 103
  • 10.4 STAGE II 104
  • 10.5 STAGE I 105
  • 10.6 STAGE 0 105

11 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP 107

  • 11.1 OVERVIEW 108
  • 11.2 GERIATRIC 111
  • 11.3 ADULTS 111
  • 11.4 PEDIATRIC 112

12 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 114

  • 12.1 OVERVIEW 115
  • 12.2 ADENOCARCINOMA 118
  • 12.3 COLORECTAL LYMPHOMA 118
  • 12.4 GASTROINTESTINAL STROMAL TUMORS 119
  • 12.5 CARCINOID TUMORS 120
  • 12.6 OTHERS 120

13 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER 122

  • 13.1 OVERVIEW 123
  • 13.2 HOSPITALS 126
  • 13.3 DIAGNOSTIC CENTERS 126
  • 13.4 CANCER RESEARCH CENTERS 127
  • 13.5 AMBULATORY SURGICAL CENTERS 128
  • 13.6 ACADEMIC INSTITUTES 128
  • 13.7 OTHERS 129

14 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION 131

  • 14.1 MIDDLE EAST AND AFRICA 132
    • 14.1.1 SOUTH AFRICA 142
    • 14.1.2 SAUDI ARABIA 147
    • 14.1.3 U.A.E. 152
    • 14.1.4 EGYPT 157
    • 14.1.5 ISRAEL 162
    • 14.1.6 REST OF MIDDLE EAST AND AFRICA 167

15 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, COMPANY LANDSCAPE 168

  • 15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 168

16 SWOT ANALYSIS 169

17 COMPANY PROFILE 170

  • 17.1 F. HOFFMANN- LA ROCHE LTD 170
    • 17.1.1 COMPANY SNAPSHOT 170
    • 17.1.2 REVENUE ANALYSIS 170
    • 17.1.3 COMPANY SHARE ANALYSIS 171
    • 17.1.4 PRODUCT PORTFOLIO 171
    • 17.1.5 RECENT DEVELOPMENT 171
  • 17.2 KONINKLIJKE PHILIPS N.V. 172
    • 17.2.1 COMPANY SNAPSHOT 172
    • 17.2.2 REVENUE ANALYSIS 172
    • 17.2.3 COMPANY SHARE ANALYSIS 173
    • 17.2.4 PRODUCT PORTFOLIO 173
    • 17.2.5 RECENT DEVELOPMENT 173
  • 17.3 THERMO FISHER SCIENTIFIC INC. 175
    • 17.3.1 COMPANY SNAPSHOT 175
    • 17.3.2 REVENUE ANALYSIS 175
    • 17.3.3 COMPANY SHARE ANALYSIS 176
    • 17.3.4 PRODUCT PORTFOLIO 176
    • 17.3.5 RECENT DEVELOPMENT 176
  • 17.4 ILLUMINA, INC. 177
    • 17.4.1 COMPANY SNAPSHOT 177
    • 17.4.2 REVENUE ANALYSIS 177
    • 17.4.3 COMPANY SHARE ANALYSIS 178
    • 17.4.4 PRODUCT PORTFOLIO 178
    • 17.4.5 RECENT DEVELOPMENT 178
  • 17.5 QUEST DIAGNOSTICS INCORPORATED 179
    • 17.5.1 COMPANY SNAPSHOT 179
    • 17.5.2 REVENUE ANALYSIS 179
    • 17.5.3 COMPANY SHARE ANALYSIS 180
    • 17.5.4 PRODUCT PORTFOLIO 180
    • 17.5.5 RECENT DEVELOPMENT 180
  • 17.6 ABBOTT 181
    • 17.6.1 COMPANY SNAPSHOT 181
    • 17.6.2 REVENUE ANALYSIS 181
    • 17.6.3 PRODUCT PORTFOLIO 182
    • 17.6.4 RECENT DEVELOPMENT 182
  • 17.7 AGILENT TECHNOLOGIES, INC. 183
    • 17.7.1 COMPANY SNAPSHOT 183
    • 17.7.2 REVENUE ANALYSIS 183
    • 17.7.3 PRODUCT PORTFOLIO 184
    • 17.7.4 RECENT DEVELOPMENT 184
  • 17.8 BD 185
    • 17.8.1 COMPANY SNAPSHOT 185
    • 17.8.2 REVENUE ANALYSIS 185
    • 17.8.3 PRODUCT PORTFOLIO 186
    • 17.8.4 RECENT DEVELOPMENT 186
  • 17.9 BEIJING O&D BIOTECH CO., LTD. 187
    • 17.9.1 COMPANY SNAPSHOT 187
    • 17.9.2 PRODUCT PORTFOLIO 187
    • 17.9.3 RECENT DEVELOPMENT 187
  • 17.10 BIOFIRE DIAGNOSTICS 188
    • 17.10.1 COMPANY SNAPSHOT 188
    • 17.10.2 REVENUE ANALYSIS 188
    • 17.10.3 PRODUCT PORTFOLIO 189
    • 17.10.4 RECENT DEVELOPMENT 189
  • 17.11 BIO-RAD LABORATORIES, INC. 190
    • 17.11.1 COMPANY SNAPSHOT 190
    • 17.11.2 REVENUE ANALYSIS 190
    • 17.11.3 PRODUCT PORTFOLIO 191
    • 17.11.4 RECENT DEVELOPMENT 191
  • 17.12 CANON MEDICAL SYSTEMS CORPORATION. 192
    • 17.12.1 COMPANY SNAPSHOT 192
    • 17.12.2 REVENUE ANALYSIS 192
    • 17.12.3 PRODUCT PORTFOLIO 193
    • 17.12.4 RECENT DEVELOPMENT 193
  • 17.13 FONAR CORP. 194
    • 17.13.1 COMPANY SNAPSHOT 194
    • 17.13.2 REVENUE ANALYSIS 194
    • 17.13.3 PRODUCT PORTFOLIO 195
    • 17.13.4 RECENT DEVELOPMENT 195
  • 17.14 FUJIFILM CORPORATION 196
    • 17.14.1 COMPANY SNAPSHOT 196
    • 17.14.2 REVENUE ANALYSIS 196
    • 17.14.3 PRODUCT PORTFOLIO 197
    • 17.14.4 RECENT DEVELOPMENT 197
  • 17.15 GE HEALTHCARE. 198
    • 17.15.1 COMPANY SNAPSHOT 198
    • 17.15.2 REVENUE ANALYSIS 198
    • 17.15.3 PRODUCT PORTFOLIO 199
    • 17.15.4 RECENT DEVELOPMENT 199
  • 17.16 HOLOGIC, INC. 200
    • 17.16.1 COMPANY SNAPSHOT 200
    • 17.16.2 REVENUE ANALYSIS 200
    • 17.16.3 PRODUCT PORTFOLIO 201
    • 17.16.4 RECENT DEVELOPMENT 201
  • 17.17 MEDONICA CO. LTD 202
    • 17.17.1 COMPANY SNAPSHOT 202
    • 17.17.2 PRODUCT PORTFOLIO 202
    • 17.17.3 RECENT DEVELOPMENT 202
  • 17.18 MERCK KGAA 203
    • 17.18.1 COMPANY SNAPSHOT 203
    • 17.18.2 REVENUE ANALYSIS 203
    • 17.18.3 PRODUCT PORTFOLIO 204
    • 17.18.4 RECENT DEVELOPMENT 204
  • 17.19 MINFOUND MEDICAL SYSTEMS CO., LTD 205
    • 17.19.1 COMPANY SNAPSHOT 205
    • 17.19.2 PRODUCT PORTFOLIO 205
    • 17.19.3 RECENT DEVELOPMENT 205
  • 17.20 MYRIAD GENETICS, INC. 206
    • 17.20.1 COMPANY SNAPSHOT 206
    • 17.20.2 REVENUE ANALYSIS 206
    • 17.20.3 PRODUCT PORTFOLIO 207
    • 17.20.4 RECENT DEVELOPMENT 207
  • 17.21 NEUSOFT CORPORATION 208
    • 17.21.1 COMPANY SNAPSHOT 208
    • 17.21.2 REVENUE ANALYSIS 208
    • 17.21.3 PRODUCT PORTFOLIO 209
    • 17.21.4 RECENT DEVELOPMENT 209
  • 17.22 PLEXBIO 210
    • 17.22.1 COMPANY SNAPSHOT 210
    • 17.22.2 PRODUCT PORTFOLIO 210
    • 17.22.3 RECENT DEVELOPMENT 210
  • 17.23 QIAGEN 211
    • 17.23.1 COMPANY SNAPSHOT 211
    • 17.23.2 REVENUE ANALYSIS 211
    • 17.23.3 PRODUCT PORTFOLIO 212
    • 17.23.4 RECENT DEVELOPMENT 212
  • 17.24 SIEMENS HEALTHCARE GMBH 213
    • 17.24.1 COMPANY SNAPSHOT 213
    • 17.24.2 REVENUE ANALYSIS 213
    • 17.24.3 1.2.3 PRODUCT PORTFOLIO 214
    • 17.24.4 RECENT DEVELOPMENT 214
  • 17.25 STERNMED GMBH 215
    • 17.25.1 COMPANY SNAPSHOT 215
    • 17.25.2 PRODUCT PORTFOLIO 215
    • 17.25.3 RECENT DEVELOPMENT 215
  • 17.26 TIME MEDICAL HOLDING. 216
    • 17.26.1 COMPANY SNAPSHOT 216
    • 17.26.2 PRODUCT PORTFOLIO 216
    • 17.26.3 RECENT DEVELOPMENT 216

18 QUESTIONNAIRE 217

19 RELATED REPORTS 220

LIST OF TABLES

  • TABLE 1 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 59
  • TABLE 2 MIDDLE EAST & AFRICA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 60
  • TABLE 3 MIDDLE EAST & AFRICA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 61
  • TABLE 4 MIDDLE EAST & AFRICA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 61
  • TABLE 5 MIDDLE EAST & AFRICA IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 62
  • TABLE 6 MIDDLE EAST & AFRICA CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 63
  • TABLE 7 MIDDLE EAST & AFRICA CONSUMABLES AND ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 64
  • TABLE 8 MIDDLE EAST & AFRICA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 64
  • TABLE 9 MIDDLE EAST & AFRICA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 65
  • TABLE 10 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 69
  • TABLE 11 MIDDLE EAST & AFRICA STOOL EXAMINATION IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 70
  • TABLE 12 MIDDLE EAST & AFRICA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 71
  • TABLE 13 MIDDLE EAST & AFRICA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 71
  • TABLE 14 MIDDLE EAST & AFRICA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 73
  • TABLE 15 MIDDLE EAST & AFRICA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 73
  • TABLE 16 MIDDLE EAST & AFRICA TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 74
  • TABLE 17 MIDDLE EAST & AFRICA TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 75
  • TABLE 18 MIDDLE EAST & AFRICA BIOPSY IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 76
  • TABLE 19 MIDDLE EAST & AFRICA OTHERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 76
  • TABLE 20 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 80
  • TABLE 21 MIDDLE EAST & AFRICA STAGE III IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 81
  • TABLE 22 MIDDLE EAST & AFRICA STAGE IV IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 82
  • TABLE 23 MIDDLE EAST & AFRICA STAGE II IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 82
  • TABLE 24 MIDDLE EAST & AFRICA STAGE I IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 83
  • TABLE 25 MIDDLE EAST & AFRICA STAGE 0 IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 84
  • TABLE 26 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 88
  • TABLE 27 MIDDLE EAST & AFRICA GERIATRIC IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 89
  • TABLE 28 MIDDLE EAST & AFRICA ADULTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 90
  • TABLE 29 MIDDLE EAST & AFRICA PEDIATRIC IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 91
  • TABLE 30 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 95
  • TABLE 31 MIDDLE EAST & AFRICA ADENOCARCINOMA IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 96
  • TABLE 32 MIDDLE EAST & AFRICA COLORECTAL LYMPHOMA IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 97
  • TABLE 33 MIDDLE EAST & AFRICA GASTROINTESTINAL STROMAL TUMORS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 97
  • TABLE 34 MIDDLE EAST & AFRICA CARCINOID TUMORS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 98
  • TABLE 35 MIDDLE EAST & AFRICA OTHERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 99
  • TABLE 36 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 103
  • TABLE 37 MIDDLE EAST & AFRICA HOSPITALS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 104
  • TABLE 38 MIDDLE EAST & AFRICA DIAGNOSTIC CENTERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 105
  • TABLE 39 MIDDLE EAST & AFRICA CANCER RESEARCH CENTERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 106
  • TABLE 40 MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 106
  • TABLE 41 MIDDLE EAST & AFRICA ACADEMIC INSTITUTES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 107
  • TABLE 42 MIDDLE EAST & AFRICA OTHERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 108
  • TABLE 43 MIDDLE EAST AND AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 114
  • TABLE 44 MIDDLE EAST AND AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 114
  • TABLE 45 MIDDLE EAST AND AFRICA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 114
  • TABLE 46 MIDDLE EAST AND AFRICA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 115
  • TABLE 47 MIDDLE EAST AND AFRICA IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 115
  • TABLE 48 MIDDLE EAST AND AFRICA CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 115
  • TABLE 49 MIDDLE EAST AND AFRICA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
  • TABLE 50 MIDDLE EAST AND AFRICA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 116
  • TABLE 51 MIDDLE EAST AND AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 116
  • TABLE 52 MIDDLE EAST AND AFRICA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 117
  • TABLE 53 MIDDLE EAST AND AFRICA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 117
  • TABLE 54 MIDDLE EAST AND AFRICA TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 117
  • TABLE 55 MIDDLE EAST AND AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 118
  • TABLE 56 MIDDLE EAST AND AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 118
  • TABLE 57 MIDDLE EAST AND AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 118
  • TABLE 58 MIDDLE EAST AND AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 119
  • TABLE 59 SOUTH AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
  • TABLE 60 SOUTH AFRICA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
  • TABLE 61 SOUTH AFRICA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 120
  • TABLE 62 SOUTH AFRICA IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
  • TABLE 63 SOUTH AFRICA CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
  • TABLE 64 SOUTH AFRICA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
  • TABLE 65 SOUTH AFRICA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
  • TABLE 66 SOUTH AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 122
  • TABLE 67 SOUTH AFRICA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 122
  • TABLE 68 SOUTH AFRICA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 122
  • TABLE 69 SOUTH AFRICA TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 123
  • TABLE 70 SOUTH AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 123
  • TABLE 71 SOUTH AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 123
  • TABLE 72 SOUTH AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 124
  • TABLE 73 SOUTH AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 124
  • TABLE 74 SAUDI ARABIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
  • TABLE 75 SAUDI ARABIA INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
  • TABLE 76 SAUDI ARABIA PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
  • TABLE 77 SAUDI ARABIA IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
  • TABLE 78 SAUDI ARABIA CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
  • TABLE 79 SAUDI ARABIA KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
  • TABLE 80 SAUDI ARABIA REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
  • TABLE 81 SAUDI ARABIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 127
  • TABLE 82 SAUDI ARABIA BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 127
  • TABLE 83 SAUDI ARABIA IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 127
  • TABLE 84 SAUDI ARABIA TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 128
  • TABLE 85 SAUDI ARABIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 128
  • TABLE 86 SAUDI ARABIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 128
  • TABLE 87 SAUDI ARABIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 129
  • TABLE 88 SAUDI ARABIA COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 129
  • TABLE 89 U.A.E. COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
  • TABLE 90 U.A.E. INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
  • TABLE 91 U.A.E. PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
  • TABLE 92 U.A.E. IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
  • TABLE 93 U.A.E. CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
  • TABLE 94 U.A.E. KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
  • TABLE 95 U.A.E. REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
  • TABLE 96 U.A.E. COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 132
  • TABLE 97 U.A.E. BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 132
  • TABLE 98 U.A.E. IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 99 U.A.E. TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 100 U.A.E. COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 133
  • TABLE 101 U.A.E. COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 134
  • TABLE 102 U.A.E. COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 134
  • TABLE 103 U.A.E. COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 134
  • TABLE 104 EGYPT COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 105 EGYPT INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 106 EGYPT PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 107 EGYPT IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 136
  • TABLE 108 EGYPT CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 136
  • TABLE 109 EGYPT KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 136
  • TABLE 110 EGYPT REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 136
  • TABLE 111 EGYPT COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 137
  • TABLE 112 EGYPT BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 137
  • TABLE 113 EGYPT IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 137
  • TABLE 114 EGYPT TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 138
  • TABLE 115 EGYPT COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 138
  • TABLE 116 EGYPT COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 138
  • TABLE 117 EGYPT COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 139
  • TABLE 118 EGYPT COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 139
  • TABLE 119 ISRAEL COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
  • TABLE 120 ISRAEL INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
  • TABLE 121 ISRAEL PATHOLOGY-BASED INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
  • TABLE 122 ISRAEL IMAGING INSTRUMENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
  • TABLE 123 ISRAEL CONSUMABLES & ACCESSORIES IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
  • TABLE 124 ISRAEL KITS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
  • TABLE 125 ISRAEL REAGENTS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 142
  • TABLE 126 ISRAEL COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 142
  • TABLE 127 ISRAEL BLOOD TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 142
  • TABLE 128 ISRAEL IMAGING TEST IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 143
  • TABLE 129 ISRAEL TUMOR MARKERS IN COLORECTAL CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 143
  • TABLE 130 ISRAEL COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 143
  • TABLE 131 ISRAEL COLORECTAL CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 144
  • TABLE 132 ISRAEL COLORECTAL CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 144
  • TABLE 133 ISRAEL COLORECTAL CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 144
  • TABLE 134 REST OF MIDDLE EAST AND AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145

LIST OF FIGURES

  • FIGURE 1 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: SEGMENTATION 24
  • FIGURE 2 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION 27
  • FIGURE 3 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: DROC ANALYSIS 28
  • FIGURE 4 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS 29
  • FIGURE 5 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 29
  • FIGURE 6 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 31
  • FIGURE 7 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 32
  • FIGURE 8 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: MARKET END USER COVERAGE GRID 33
  • FIGURE 9 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 34
  • FIGURE 10 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: SEGMENTATION 38
  • FIGURE 11 THE INCREASE IN THE AWARENESS ABOUT COLORECTAL CANCER IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET GROWTH IN THE FORECAST PERIOD 39
  • FIGURE 12 THE INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET IN 2023 & 2030 39
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET 47
  • FIGURE 14 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2022 55
  • FIGURE 15 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 56
  • FIGURE 16 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 56
  • FIGURE 17 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, LIFELINE CURVE 57
  • FIGURE 18 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022 65
  • FIGURE 19 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 66
  • FIGURE 20 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030) 66
  • FIGURE 21 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE 67
  • FIGURE 22 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, 2022 76
  • FIGURE 23 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, 2023-2030 (USD MILLION) 77
  • FIGURE 24 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, CAGR (2023-2030) 77
  • FIGURE 25 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, LIFELINE CURVE 78
  • FIGURE 26 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2022 84
  • FIGURE 27 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2023-2030 (USD MILLION) 85
  • FIGURE 28 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, CAGR (2023-2030) 85
  • FIGURE 29 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY AGE GROUP, LIFELINE CURVE 86
  • FIGURE 30 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2022 91
  • FIGURE 31 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2023-2030 (USD MILLION) 92
  • FIGURE 32 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, CAGR (2023-2030) 92
  • FIGURE 33 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, LIFELINE CURVE 93
  • FIGURE 34 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, 2022 99
  • FIGURE 35 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD MILLION) 100
  • FIGURE 36 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030) 100
  • FIGURE 37 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 101
  • FIGURE 38 MIDDLE EAST AND AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 109
  • FIGURE 39 MIDDLE EAST AND AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 110
  • FIGURE 40 MIDDLE EAST AND AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 110
  • FIGURE 41 MIDDLE EAST AND AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 111
  • FIGURE 42 MIDDLE EAST AND AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030) 111
  • FIGURE 43 MIDDLE EAST & AFRICA COLORECTAL CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 144
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!